查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年亞太地區微載體市場預測 - 區域分析 - 按產品、設備、應用和最終用戶
市場調查報告書
商品編碼
1494454

2030 年亞太地區微載體市場預測 - 區域分析 - 按產品、設備、應用和最終用戶

Asia Pacific Microcarriers Market Forecast to 2030 - Regional Analysis - by Product, Equipment, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 96 Pages | 訂單完成後即時交付

價格

亞太地區微載體市場預計將從2022年的3.6614億美元成長到2030年的9.9123億美元。

再生醫學採用激增推動亞太微載體市場

再生醫學的日益普及已成為推動微載體市場成長的重要驅動力。再生醫學專注於修復、替換或再生受損的組織和器官，使其成為解決各種醫療狀況的一個有前景的領域。微載體在細胞培養和擴增中發揮關鍵作用，這是再生醫學的一個基本面向。

在再生醫學中，細胞在移植前在體外培養，微載體為細胞附著、增殖和分化提供合適的環境。它們作為生物反應器中細胞生長的基質，促進大量細胞的高效生產。這對於需要大量活細胞和功能細胞的再生療法尤其重要。

此外，微載體增強了細胞過程的可擴展性和成本效益，解決了再生醫學從研究到臨床應用轉化的關鍵挑戰。隨著再生醫學領域的不斷發展，以及對幹細胞療法和組織工程的日益關注，對微載體的需求預計將不斷升級，從而推動微載體市場的創新和擴張

亞太地區微載體市場概況

亞太地區的微載體市場分為中國、日本、印度、澳洲、韓國和亞太其他國家。亞太地區的一些國家在細胞和基因治療研發方面投入大量資金。中國、印度和日本是該地區微載體市場成長的三個主要貢獻者，市場成長可歸因於企業對成本最佳化的日益重視、簡化臨床流程的快速努力、政府的支持政策、以及越來越多的臨床試驗。中華人民共和國政府致力於改善公共衛生，提供具有成本效益的公共衛生計劃，擴大與健康相關的財政保障措施的覆蓋範圍，並投資於龐大的醫療服務網路。十三五規劃預計，2020年生技產業對GDP的貢獻率將超過4%，接近生命科學的10-20倍。中國有100多個由地方政府控制的生命科學園區正在運作，這些中心以稅收優惠和補貼吸引企業。據報道，為了實現中國五年計畫的目標，國家、省和地方政府已在生物科學領域投資超過1,000億美元。 2003年，它成為第一個批准基因療法的國家，從那時起，具有更高治療潛力的細胞和基因療法的開發在全球範圍內加快了步伐。根據 2021 年《自然》雜誌發表的一項研究，全球超過 50% 的細胞治療試驗都在中國進行。該國目前有近 400 項正在進行的 CAR-T 試驗，重點是血液學、腫瘤學和實體腫瘤。 2021年，國家藥品監督管理局（NMPA）批准了復星凱特的Yescarta和JW Therapeutics的Relma-cel，中國的細胞治療進入了新時代。

亞太地區微載體市場營收及 2030 年預測（百萬美元）

亞太地區微載體市場區隔

亞太地區微載體市場分為產品、設備、應用、最終用戶和國家。

根據產品，亞太微載體市場分為微載體珠和培養基和試劑。 2022 年，微載體珠細分市場在亞太微載體市場中佔有更大佔有率。

在設備方面，亞太微載體市場分為生物反應器、培養皿等。 2022 年，生物反應器領域佔據亞太微載體市場的最大佔有率。

根據應用，亞太微載體市場分為生物製藥生產、細胞和基因治療、組織工程和再生醫學等。 2022年，生物製藥生產領域在亞太微載體市場中佔據最大佔有率。

根據最終用戶，亞太微載體市場分為製藥和生物技術公司、合約研究組織和合約製造組織以及學術和研究機構。 2022 年，製藥和生物技術公司領域佔據亞太微載體市場的最大佔有率。

根據國家/地區，亞太地區微載體市場分為中國、日本、印度、韓國、澳洲和亞太地區其他地區。 2022年，中國將主導亞太微載體市場。

Teijin Ltd、Bio-Rad Laboratories Inc、Sartorius AG、Danaher Corp、Corning Inc、Eppendorf SE、Asahi Kasei Corp 和 Polysciences Inc 是亞太微載體市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區微載體市場 - 主要產業動態

  • 主要市場促進因素：
    • 隨著癌症和傳染病發病率的上升，對細胞療法的需求
    • 外包細胞和基因治療製造越來越受歡迎
    • 再生醫學的採用激增
  • 市場限制
    • 生物製劑和細胞療法的高成本
  • 市場機會
    • 微載體製造商的策略性舉措和創新產品
  • 未來的趨勢
    • 細胞和基因治療製造服務的自動化
  • 影響分析

第 5 章：微載體市場 - 亞太市場分析

  • 微載體市場收入，2022 - 2030

第 6 章：亞太地區微載體市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年和 2030 年按產品分類的微載體市場收入佔有率 (%)
  • 微載體珠
  • 介質和試劑

第 7 章：亞太地區微載體市場 - 收入和 2030 年預測 - 按設備

  • 概述
  • 2022 年及 2030 年按設備分類的微載體市場收入佔有率 (%)
  • 生物反應器
  • 培養容器
  • 其他

第 8 章：亞太地區微載體市場 - 2030 年收入與預測 - 按應用

  • 概述
  • 2022 年和 2030 年按應用分類的微載體市場收入佔有率 (%)
  • 生物製藥生產
  • 細胞和基因治療
  • 組織工程與再生醫學
  • 其他

第 9 章：亞太地區微載體市場收入和 2030 年預測 - 最終用戶

  • 概述
  • 亞太地區最終用戶微載體市場佔有率 - 2022 年和 2030 年 (%)
  • 製藥和生物技術公司
    • 概述
    • 製藥和生物技術公司：微載體市場 - 收入和 2030 年預測
  • 合約研究組織和合約製造組織
    • 概述
    • 合約研究組織和合約製造組織：微載體市場 - 收入和 2028 年預測
  • 學術及研究機構
    • 概述
    • 學術和研究機構：微載體市場 - 收入和 2028 年預測

第 10 章：亞太地區微載體市場收入和 2030 年預測 - 國家分析

    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 亞太地區其他地區

第 11 章：微載體市場-產業格局

  • 概述
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Asahi Kasei Corp
  • Polysciences Inc

第 13 章：附錄

Product Code: BMIRE00029978

The Asia Pacific microcarriers market is expected to grow from US$ 366.14 million in 2022 to US$ 991.23 million by 2030. It is estimated to record a CAGR of 13.3% from 2022 to 2030.

Surge in Adoption of Regenerative Medicine Fuels Asia Pacific Microcarriers Market

The rising adoption of regenerative medicine has emerged as a significant driver propelling the growth of the microcarriers market. Regenerative medicine focuses on repairing, replacing, or regenerating damaged tissues and organs, making it a promising field for addressing various medical conditions. Microcarriers play a pivotal role in the cultivation and expansion of cells, a fundamental aspect of regenerative medicine.

In regenerative medicine, cells are cultured outside the body before being transplanted, and microcarriers provide a suitable environment for cell attachment, proliferation, and differentiation. They serve as a substrate for cell growth in bioreactors, facilitating the efficient production of large quantities of cells. This is particularly crucial for regenerative therapies, where a substantial number of viable and functional cells are needed.

Moreover, microcarriers enhance the scalability and cost-effectiveness of cell processes, addressing key challenges in the translation of regenerative medicine from research to clinical applications. As the regenerative medicine field continues to advance, with an increasing focus on stem cell therapies and tissue engineering, the demand for microcarriers is expected to escalate, driving innovation and expansion within the microcarriers market

Asia Pacific Microcarriers Market Overview

The microcarrier market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific countries. Several countries in Asia Pacific invest significantly in cell and gene therapy R&D. China, India, and Japan are the three major contributors to the growth of the microcarriers market in this region, and the market growth can be attributed to the growing emphasis of businesses on cost optimization, burgeoning efforts to streamline clinical processes, supportive government policies, and increasing number of clinical trials. The government of the People's Republic of China is focused on improving public health, providing cost-effective public health programs, expanding the coverage of health-related financial protection measures, and investing in a vast healthcare delivery network. The 13th Chinese plan expected a more than 4% contribution of the biotechnology industry to the GDP in 2020, which would be nearly 10-20 life-science parities. More than 100 life-science parks controlled by local governments are functional across China, and these centers entice enterprises with tax advantages and subsidies. State, provincial, and local governments are reported to have already invested more than US$ 100 billion in the biosciences sector to meet the goals of the five-year plan of China. In 2003, it became the first country to approve a gene therapy, and since then, the development of cell and gene therapies with elevated therapeutic potential has picked pace worldwide. According to a study published in Nature in 2021, China is home to more than 50% of all cell therapy trials across the world. The country currently has nearly 400 ongoing CAR-T trials centered on hematology, and oncology and solid tumors. In 2021, the National Medical Products Administration (NMPA) approved Fosun Kite's Yescarta and JW Therapeutics' Relma-cel, with which cell therapies in China entered a new era.

Asia Pacific Microcarriers Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Microcarriers Market Segmentation

The Asia Pacific microcarriers market is segmented into product, equipment, application, end user, and country.

Based on product, the Asia Pacific microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the Asia Pacific microcarriers market in 2022.

In terms of equipment, the Asia Pacific microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the Asia Pacific microcarriers market in 2022.

Based on application, the Asia Pacific microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the Asia Pacific microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the Asia Pacific microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the Asia Pacific microcarriers market in 2022.

Based on country, the Asia Pacific microcarriers market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific microcarriers market in 2022.

Teijin Ltd, Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the Asia Pacific microcarriers market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Microcarriers Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surge in Adoption of Regenerative Medicine
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Biologics and Cell-based Therapies
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 4.4 Future Trends
    • 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 4.5 Impact Analysis

5. Microcarriers Market - Asia Pacific Market Analysis

  • 5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Microcarrier Beads
    • 6.3.1 Overview
    • 6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Media and Reagents
    • 6.4.1 Overview
    • 6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 7.3 Bioreactors
    • 7.3.1 Overview
    • 7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Culture Vessels
    • 7.4.1 Overview
    • 7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Biopharmaceutical Production
    • 8.3.1 Overview
    • 8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell and Gene Therapy
    • 8.4.1 Overview
    • 8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Tissue Engineering and Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 9.1 Overview
  • 9.2 Asia Pacific Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Microcarriers Market Revenue and Forecasts to 2030 - Country Analysis

  • 10.1 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Microcarriers Market, by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
        • 10.1.2.1.3 China: Microcarriers Market, by Product
        • 10.1.2.1.4 China: Microcarriers Market, by Equipment
        • 10.1.2.1.5 China: Microcarriers Market, by Application
        • 10.1.2.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.1.6 China: Microcarriers Market, by End User
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Japan: Microcarriers Market, by Product
        • 10.1.2.2.4 Japan: Microcarriers Market, by Equipment
        • 10.1.2.2.5 Japan: Microcarriers Market, by Application
        • 10.1.2.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.2.6 Japan: Microcarriers Market, by End User
      • 10.1.2.3 India
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 India: Microcarriers Market, by Product
        • 10.1.2.3.4 India: Microcarriers Market, by Equipment
        • 10.1.2.3.5 India: Microcarriers Market, by Application
        • 10.1.2.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.3.6 India: Microcarriers Market, by End User
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
        • 10.1.2.4.3 Australia: Microcarriers Market, by Product
        • 10.1.2.4.4 Australia: Microcarriers Market, by Equipment
        • 10.1.2.4.5 Australia: Microcarriers Market, by Application
        • 10.1.2.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.4.6 Australia: Microcarriers Market, by End User
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 South Korea: Microcarriers Market, by Product
        • 10.1.2.5.4 South Korea: Microcarriers Market, by Equipment
        • 10.1.2.5.5 South Korea: Microcarriers Market, by Application
        • 10.1.2.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.5.6 South Korea: Microcarriers Market, by End User
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
        • 10.1.2.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
        • 10.1.2.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
        • 10.1.2.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.6.6 Rest of Asia Pacific: Microcarriers Market, by End User

11. Microcarriers Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Teijin Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bio-Rad Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sartorius AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Danaher Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Corning Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eppendorf SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Asahi Kasei Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Polysciences Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. China Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. China Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. China Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. China Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. China: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. Japan Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. Japan Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. Japan Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. Japan Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. Japan: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. India Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. India Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. India Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. India Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. India: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Australia Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 18. Australia Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 19. Australia Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Australia Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 21. Australia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 22. South Korea Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 23. South Korea Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 24. South Korea Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 25. South Korea Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 26. South Korea: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 27. Rest of Asia Pacific Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 28. Rest of Asia Pacific Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 29. Rest of Asia Pacific Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Rest of Asia Pacific Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. Recent Organic Growth Strategies in Microcarriers Market
  • Table 33. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Microcarriers Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 10. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Microcarriers Market, 2022 (US$Mn)
  • Figure 25. Asia Pacific: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 26. China: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Australia: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)